Neovasc uses conference to announce positive interim clinical data from Neovasc Reducer use - Bill Little, COO, Neovasc Inc 00:00:00
Neovasc COO Bill Little joined Steve Darling from Proactive to share news the company has announced positive data at the Transcatheter Cardiovascular Therapeutics Conference on use of the Neovasc Reducer in patients who have angina with non-obstructive coronary artery disease.